Fish oil supplements rich in omega-3 fatty acids are not beneficial for patients at high risk of cardiovascular troubles and already being medicated, a study found Wednesday. In the study, carried out in 2010 in Italy with 12,513 patients, half the group took an omega-3 supplement and the other half an olive oil placebo. Previous clinical trials have suggested that these supplements could reduce cardiovascular risks for patients suffering from cardiovascular disease or who have already suffered cardiac arrest. But a major study in 2010 found that the fish oil supplements did not help prevent atrial fibrillation, a common problem with the heartbeat’s rate or rhythm. The latest research found that just under 12 percent of patients in both groups — 11.7 percent of the omega-3 group and 11.9 percent of the placebo group — experienced a stroke. “In a large general-practice cohort of patients with multiple cardiovascular risk factors, daily treatment with n-3 fatty acids did not reduce cardiovascular mortality and morbidity,” the study concluded. The research was led by Mario Negri at the Societa Prodotti Antibiotici in Milan. Source: Khaleej Times
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor